Trial NCT03422523

View at ClinicalTrials.gov 
Org. Study IDs: RHM CAN1219
Secondary IDs: 2016-002654-21

Last trial update was posted on 2022-08-22

MeSH Interventions

Atezolizumab Gemcitabine Oxaliplatin Rituximab

MeSH Conditions

Lymphoma Lymphoma, B-Cell Lymphoma, Large B-Cell, Diffuse

Other Conditions

Diffuse Large B Cell Lymphoma Refractory Diffuse Large B-Cell Lymphoma Relapsed Diffuse Large B-Cell Lymphoma

Stopping Reasons

Failure to reach pre-specified futility boundary

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID